Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Focus on sildenafil for erectile dysfunction

April 16, 1997

Amgen and Roche extend EU collaboration on G-CSF products

April 16, 1997

Optimal dose of sertraline for premature ejaculation

April 16, 1997

Esters of estrogenic compounds from Lilly

April 16, 1997

Norian seeks FDA approval for orthopedic applications of Norian SRS

April 15, 1997

Nitrosylated alpha-adrenoceptor antagonists for erectile dysfunction

April 15, 1997

Melanotropic peptide effective in men with erectile dysfunction

April 15, 1997

Moxisylyte recommended as first-line therapy for erectile dysfunction

April 15, 1997

Transurethral alprostadil/prazosin for erectile dysfunction

April 15, 1997

Fluoxetine for the management of premature ejaculation

April 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...